Resistance to Imipenem Among Selected Gram-Negative Bacilli in the United States

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Infection Control & Hospital Epidemiology

• Publication date

  1992-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/646417PMID 1545108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem

  1991cited by this paper
• National nosocomial infections surveillance system (NNIS): description of surveillance methods.

  1991cited by this paper
• Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa

  1990cited by this paper
• Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa

  1989cited by this paper
• CDC definitions for nosocomial infections.

  1989cited by this paper
• CDC definitions for nosocomial infections, 1988.

  1988cited by this paper
• Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein

  1987cited by this paper
• Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

  1986cited by this paper
• Empirical use of imipenem as the sole antibiotic in the treatment of serious infections.

  1985cited by this paper
• Effect of hypoxemia on sodium and water excretion in chronic obstructive lung disease.

  1985cited by this paper
• Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience.

  1985cited by this paper
• Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis.

  1985cited by this paper
• Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infections.

  1985cited by this paper
• Pneumonia treated with imipenem/cilastatin.

  1985cited by this paper
• Imipenem/cilastatin therapy of bacteremia.

  1985cited by this paper
• STATISTICAL METHODS

  1967cited by this paper

• The Prevalence of Colonization with Carbapenem-resistant Enterobacteriaceae, E. coli, Klebsiella and Enterobacter, and Related Risk Factors in Children

  2023cites this paper
• Evaluation of three different methods for susceptibility testing of gentamicin in carbapenem resistant Enterobacterales.

  2021cites this paper
• Characterization of the Genetic Background of KPC-2-Producing Klebsiella pneumoniae with Insertion Elements Disrupting the ompK36 Porin Gene

  2020cites this paper
• Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections

  2019cites this paper
• CG258 Klebsiella pneumoniae isolates without &bgr;-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City

  2018cites this paper
• Hydrothermal evolution of PF-co-doped TiO2 nanoparticles and their antibacterial activity against carbapenem-resistant Klebsiella pneumoniae

  2018cites this paper
• Carbapenem-resistant Enterobacteriaceae

  2017cites this paper
• Trends in the Annual Incidence of Carbapenem Resistant among Gram Negative Bacilli in a Large Teaching Hospital in Makah City, Saudi Arabia

  2017cites this paper
• Ciprofloxacin and imipenem resistance and cross-resistance in Pseudomonas aeruginosa: A single institution experience.

  2016cites this paper
• Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae.

  2016cites this paper
• A Model-Based Strategy to Control the Spread of Carbapenem-Resistant Enterobacteriaceae: Simulate and Implement

  2016cites this paper
• Comparison of Molecular and Phenotypic Methods for the Detection and Characterization of Carbapenem Resistant Enterobacteriaceae.

  2016cites this paper
• Emergence of Carbapenemase-producing Enterobacteriaceae, a Public Health Threat: a Romanian Infectious Disease Hospital Based Study / Emergenţa Enterobacteriaceaelor producătoare de carbapenemaze, o ameninţare pentru sănătatea publică: un studiu realizat într-un spital romanesc de boli infectioase

  2015cites this paper
• IncIdêncIa de Infecções por enterobactérIas resIstentes

  2015cites this paper
• Bacterial Infections and Drug Resistant Pathogens ( H Wisplinghoff , Section Editor ) Combination Antibiotic Therapy for the Definitive Management of Select Multidrug-Resistant Gram-Negative Rod Infections

  2015cites this paper
• Characterization of resistance genes in 68 ESBL-producing Klebsiella pneumonia in Lebanon.

  2014cites this paper
• Determining the Presence of Carbapenem Antibiotic Resistance in Clinical Isolates

  2014influential citation
• Characterization of the blaKPC-2 and blaKPC-3 genes and the novel blaKPC-15 gene in Klebsiella pneumoniae.

  2014cites this paper
• Spectroscopic investigations of the binding mechanisms between antimicrobial peptides and membrane models of Pseudomonas aeruginosa and Klebsiella pneumoniae.

  2014cites this paper
• Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings?

  2013cites this paper
• Fatal and Nonfatal Injuries Involving Fishing Vessel Winches — Southern Shrimp Fleet, United States, 2000–2011

  2013cites this paper
• Public health need versus sales of antibacterial agents active against multidrug-resistant bacteria: a historical perspective

  2013cites this paper
• Vital Signs: Carbapenem-Resistant Enterobacteriaceae

  2013cites this paper
• Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports

  2012cites this paper
• Imipenem/Cilastatin

  2012cites this paper
• ASSESSMENT OF THE APPROPRIATE UTILIZATION OF IMIPENEM/CILASTATIN IN A TERTIARY CARE HOSPITAL

  2011cites this paper
• Carbapenem-Resistant Enterobacteriaceae : Epidemiology and Prevention

  2011cites this paper
• Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

  2011cites this paper
• Antimicrobial susceptibility of some respiratory tract pathogens to commonly used antibiotics at the Specialist Hospital, Yola, Adamawa State, Nigeria

  2010cites this paper
• RECENT INCREASES IN RESISTANCE: MECHANISMS AND ORGANISMS Evolution and Dissemination of /3-Lactamases Accelerated by Generations of (3-Lactam Antibiotics

  2010cites this paper
• Empiric, Broad-Spectrum Antibiotic Therapy with an Aggressive De-Escalation Strategy Does Not Induce Gram-Negative Pathogen Resistance in Ventilator-Associated Pneumonia

  2010cites this paper
• Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality.

  2009cites this paper
• Clinical Studies Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients

  2008cites this paper
• Imipenem-Resistant Pseudomonas aeruginosa: Risk Factors for Nosocomial Infections

  2008cites this paper
• Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients.

  2008cites this paper
• Correlation between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a medical-surgical intensive care unit

  2008cites this paper
• The contribution of antibiotic use on the frequency of antibiotic resistance in hospitals.

  2007cites this paper
• Mecanismos de resistencia a carbapenems en P. aeruginosa, Acinetobacter y Enterobacteriaceae y estrategias para su prevención y control

  2006cites this paper
• Changes in antibiotic resistance of the most common Gram-negative bacteria isolated in intensive care units.

  2005cites this paper
• Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections.

  2005cites this paper
• Risk Factors for the Acquisition of Carbapenem-Resistant Klebsiella pneumoniae among Hospitalized Patients

  2005influential citation
• In Vitro and In Vivo Activities of Novel 6-Methylidene Penems as β-Lactamase Inhibitors

  2004cites this paper
• In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors.

  2004cites this paper
• Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000.

  2004cites this paper
• Epidemiological Risk Factors for Isolation of Ceftriaxone-Resistant versus -Susceptible Citrobacter freundii in Hospitalized Patients

  2003cites this paper
• Imipenem resistance in nonfermenters causing nosocomial urinary tract infections.

  2003cites this paper
• Prophylactic antibiotics alter the bacteriology of infected necrosis in severe acute pancreatitis.

  2002cites this paper
• Antimicrobial Drug Resistance in Pathogens Causing Nosocomial Infections at a University Hospital in Taiwan, 1981-1999

  2002cites this paper
• Antimicrobial activity of imipenem against isolates from complicated urinary tract infections.

  2002cites this paper
• Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients.

  2002cites this paper
• Risk Factors for Piperacillin-Tazobactam-Resistant Pseudomonas aeruginosa among Hospitalized Patients

  2002cites this paper
• Survey of antibiotic resistance in Pseudomonas aeruginosa by The Tokyo Johoku Association of Pseudomonas Studies

  2001cites this paper
• Imipenem Consumption and Gram-Negative Pathogen Resistance to Imipenem at Sestre Milosrdnice University Hospital

  2001cites this paper
• [Hormonal contraception and epilepsy].

  2001cites this paper
• Häufigkeit und Erfassung nosokomialer Infektionen in der Technischen Orthopädie

  2001cites this paper
• Monotherapy versus combination therapy for bacterial infections.

  2000cites this paper
• Emergence of Enterobacter aerogenes as a major antibiotic-resistant nosocomial pathogen in Belgian hospitals.

  1999cites this paper
• Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients.

  1999cites this paper
• Carbapenems and monobactams: imipenem, meropenem, and aztreonam.

  1999cites this paper
• Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosa

  1999cites this paper
• Antimicrobial Use and Resistance in Eight US Hospitals: Complexities of Analysis and Modeling

  1998cites this paper
• [Imipenem resistance in Pseudomonas aeruginosa].

  1998cites this paper
• Clinical problems posed by multiresistant nonfermenting gram-negative pathogens.

  1998cites this paper
• Empiric therapy of sepsis in the surgical intensive care unit with broad-spectrum antibiotics for 72 hours does not lead to the emergence of resistant bacteria.

  1998cites this paper
• Utility of Serial Rectal Swab Cultures for Detection of Ceftazidime- and Imipenem-Resistant Gram-Negative Bacilli from Patients in the Intensive Care Unit

  1998cites this paper
• Clinical strategies for serious infection: a North American perspective.

  1998cites this paper
• Surveillance for the emergence and dissemination of antimicrobial resistance in bacteria.

  1997cites this paper
• The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals.

  1997cites this paper
• Secular trends in bloodstream infection caused by antimicrobial-resistant bacteria in New Jersey hospitals, 1991 to 1995.

  1997cites this paper
• Effect of zinc concentration in Mueller-Hinton agar on susceptibility of Pseudomonas aeruginosa to imipenem

  1997cites this paper
• Epidemiological Analysis of Clinically Isolated Pseudomonas aeruginosa

  1997cites this paper
• [Old and new antibiotics in pneumology].

  1997cites this paper
• Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.

  1997cites this paper
• Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns.

  1997cites this paper
• Viejos y nuevos antibióticos en neumología

  1997cites this paper
• Antibiotic resistance among gram-negative nosocomial pathogens in the intensive care unit: results of 6-year body-site monitoring.

  1997cites this paper
• Treatment of urinary tract infections: selecting an appropriate broad-spectrum antibiotic for nosocomial infections.

  1996cites this paper
• [Clinical infectiology--I. Diagnosis, pathogen spectrum and resistance].

  1996cites this paper
• Nosocomial Infection Caused by Antibiotic-Resistant Organisms in the Intensive-Care Unit

  1996cites this paper
• Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

  1996cites this paper
• The Need for Surveillance for Antimicrobial Resistance

  1995cites this paper
• Antibiotic resistance in ICUs: a multifaceted problem requiring a multifaceted solution.

  1995cites this paper
• Surveillance of Antibiotic Resistance: Learning to Live With Bias

  1995cites this paper
• Ciprofloxacin Resistance Among Nosocomial Pseudomonas aeruginosa and staphylococcus aureus in the United States

  1995cites this paper
• Development of resistance to imipenem among nosocomial isolates ofPseudomonas aeruginosa

  1995cites this paper
• Community Exposure Predicts Healthcare Worker TB Skin-Test Conversion

  1995cites this paper
• Mechanisms of resistance to the carbapenems.

  1995cites this paper
• The use and misuse of new antibiotics. A perspective.

  1995cites this paper
• Antibiotic-resistant gram-negative bacteria in the critical care setting.

  1995cites this paper
• Antibiotic Resistance in ICUs: A Multifaceted Problem Requiring a Multifaceted Solution

  1995cites this paper
• Ventilator-associated pneumonia caused by Pseudomonas infection.

  1995cites this paper
• Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2

  1995cites this paper
• Resistance to imipenem in Pseudomonas aeruginosa.

  1995cites this paper
• Emergence of multidrug-resistant isolates of Acinetobacter baumannii.

  1994cites this paper
• Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System.

  1994cites this paper
• Évolution de la résistance à l'imipénème de Pseudomonas aeruginosa en réanimation polyvalente

  1994cites this paper
• Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam.

  1994cites this paper
• Imipenem resistance among gram-negative bacilli

  1994cites this paper
• Imipenem stability in a predried susceptibility panel

  1994cites this paper
• Infection problems for the 1990's--do we have an answer?

  1993cites this paper